Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASSESSing the Impact of Decipher on Practice Decision Making in Prostate Cancer After Surgery

NCT02034825 is registered in ClinicalTrials.gov with GenomeDx Biosciences Corp as lead sponsor.

NCT NCT02034825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02034825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASSESSing the Impact of Decipher on Practice Decision Making in Prostate Cancer After Surgery
Lead sponsor
GenomeDx Biosciences Corp
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
January 31, 2015
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer